![]() |
市場調查報告書
商品編碼
2041791
數位心理治療市場預測至2034年—按類型、解決方案、經營模式、應用、最終用戶和地區分類的全球分析Digital Psychotherapeutics Market Forecasts to 2034 - Global Analysis By Type, Solution, Business Model, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球數位心理治療市場規模將達到 22 億美元,在預測期內將以 27.6% 的複合年成長率成長,到 2034 年將達到 154.7 億美元。
數位心理治療是指利用行動應用程式和線上平台等數位技術,針對心理健康問題進行的治療性介入。這些方案通常融合了實證治療技術,例如認知行為療法(CBT)和正念療法,為尋求心理健康服務的人提供便利的遠距支持。
根據澳洲統計局的數據,2022年,21.5%的人口在過去12個月內經歷過精神障礙,其中焦慮症最為常見(16至85歲人群中佔17.2%)。此外,全球每八個人中就有一人患有某種形式的精神障礙。
精神健康障礙日益增多
由於社會壓力增加、經濟不確定性增加以及數位時代的影響,心理健康障礙的發生率正在飆升。現代生活方式,例如高壓的職場環境和持續的網路連接,也可能加劇心理健康挑戰,並導致心理健康障礙盛行率顯著上升。數位心理療法利用科技提供擴充性介入措施,使心理健康支持更加普及。隨著個人和醫療保健專業人員越來越依賴數位解決方案來應對日益嚴峻的心理健康挑戰,這種需求的激增正在推動市場擴張。
資料隱私和安全問題
心理健康數據高度敏感,極易成為網路威脅的目標,可能導致未授權存取和濫用。患者可能由於擔心隱私外洩而對採用數位心理治療方案猶豫不決。雖然強大的加密和身份驗證機制對於建立用戶信任至關重要,但資料外洩的持續威脅仍然是一項重大挑戰,也是阻礙數位心理治療廣泛應用的因素。
使用者友善平台和應用程式的興起
使用者友善平台和應用程式正利用以使用者為中心的設計和先進技術,提高人們獲取和參與心理健康干預措施的途徑。這些新興平台專注於便利性和個人化體驗,正在觸及更廣泛的使用者群體,並加速數位化心理療法的普及。隨著人們對便利心理健康解決方案的需求持續成長,這些用戶友善應用程式有望推動市場擴張。
與傳統療法的競爭
儘管數位化解決方案在便利性和可及性方面具有優勢,但部分個人和醫療專業人員可能仍然更傾向於或依賴傳統療法。人們對數位化心理療法的有效性和可靠性持懷疑態度,這可能會阻礙其普及。對既有療法的信任以及傳統療法的個人化特點,加劇了市場競爭。因此,傳統治療方法的既有聲譽和長期認可度對市場發展構成了重大挑戰。
新冠疫情的感染疾病
新冠疫情顯著加速了數位心理治療的普及,全球心理健康挑戰日益嚴峻,需求也隨之激增。人們對心理健康的日益關注,加上封鎖和社交距離等措施,促使人們轉向遠端和數位化心理健康解決方案。遠距治療平台、心理健康應用程式和虛擬支援工具的日益普及推動了數位心理治療市場的發展。
在預測期內,穿戴式裝置產業預計將成為最大的產業。
穿戴式裝置市場預計將迎來顯著成長。穿戴式裝置透過將科技融入心理健康干預措施,在數位心理治療中發揮著至關重要的作用。這些設備通常佩戴在身上,能夠收集即時生理數據,從而實現個人化、數據驅動的治療。監測生命徵象、睡眠模式和活動量可以提高治療效果,並為治療師提供客觀的見解。這種持續的數據流有助於進行更有針對性的干涉,並允許及時調整治療方案。
在預測期內,焦慮症細分市場預計將呈現最高的複合年成長率。
在預測期內,焦慮症領域預計將呈現最高的複合年成長率。數位心理療法透過提供便利、個人化和擴充性的介入措施,為焦慮症的治療提供了極具前景的解決方案。這些平台通常融合了實證治療技術、認知行為療法模組、正念練習等多種方法,以緩解焦慮症狀。這種便捷靈活的心理健康服務方式正在推動該領域的需求成長。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於人們對心理健康問題的日益關注、智慧型手機普及率的提高以及技術的進步。新冠感染疾病對心理健康的影響提升了該地區對遠端醫療的接受度。中國以其強大的技術基礎設施而聞名,在遠端醫療、行動醫療應用和穿戴式裝置方面取得了顯著進展。因此,遠端醫療和數位健康技術的穩步發展預計將繼續推動該地區的成長。
由於北美地區擁有良好的健保報銷環境,預計在預測期內,該地區的複合年成長率(CAGR)將最高。隨著人們對心理健康意識的提高,美國的數位化心理治療產業有望蓬勃發展。焦慮症、憂鬱症和創傷後壓力症候群(PTSD)是美國常見的心理健康問題。北美地區在推動創新和普及數位化心理治療方面發揮著至關重要的作用,引領著數位化心理治療的未來發展。該地區完善的醫療保健基礎設施,以及人們對數位化干預措施日益成長的接受度,正在推動市場擴張。
According to Stratistics MRC, the Global Digital Psychotherapeutics Market is accounted for $2.20 billion in 2026 and is expected to reach $15.47 billion by 2034 growing at a CAGR of 27.6% during the forecast period. Digital psychotherapeutics refers to the use of digital technologies, such as mobile apps and online platforms, to deliver therapeutic interventions for mental health issues. These solutions often incorporate evidence-based therapeutic techniques, such cognitive-behavioural therapy (CBT) or mindfulness, and can provide remote and accessible support to individuals seeking mental health care.
According to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16-85 years). In addition, 1 out of every 8 individuals in this world suffers from a psychological disorder.
Increasing mental health disorders
The heightened societal stressors, economic uncertainties and the impact of the digital age surge in mental health disorders. Also, modern lifestyles, with high-pressure work environments and constant connectivity, may exacerbate mental health challenges, leading to a notable increase in the prevalence of mental health disorders. Digital psychotherapeutics leverage technology to offer scalable, personalized interventions, making mental health support more widely available. This surge in demand is driving the expansion of the market, as individuals and healthcare providers increasingly turn to digital solutions to address the escalating challenges associated with mental health disorders.
Data privacy & security concerns
The sensitive nature of mental health data makes it a prime target for cyber threats, potentially leading to unauthorized access and misuse. Patients may hesitate to adopt digital psychotherapeutic solutions due to fears of breaches in confidentiality. Building robust encryption and authentication mechanisms is crucial to instill trust among users, but the persistent threat of data breaches remains a key challenge, impeding the widespread adoption of digital psychotherapeutics.
Rising user-friendly platforms & apps
The user-friendly platforms and apps leverage user-centric design and advanced technologies to enhance accessibility and engagement in mental health interventions. With a focus on convenience and personalized experiences, these rising platforms cater to a broader audience, fostering increased adoption of digital psychotherapeutics. As the demand for accessible mental health solutions continues to rise, the market is poised for expansion through these user-friendly applications.
Competition with traditional therapies
While the convenience and accessibility of digital solutions offer advantages, some individuals and healthcare providers may still prefer or rely on traditional therapeutic approaches. Skepticism around the efficacy and reliability of digital psychotherapeutics may impede their acceptance. Trust in well-known methods and the personalized nature of traditional therapy contributes to the competitive landscape. Therefore, the established reputation and long-standing acceptance of traditional therapeutic methods pose a significant challenge for the market to gain traction.
Covid-19 Impact
The covid-19 pandemic has significantly accelerated the adoption of Digital Psychotherapeutics, witnessing a surge in demand as mental health challenges escalated globally. The increased awareness of mental well-being, coupled with lockdowns and social distancing measures, prompted a shift towards remote and digital mental health solutions. Teletherapy platforms, mental health apps, and virtual support tools experienced heightened acceptance, driving the digital psychotherapeutics market.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in digital psychotherapeutics by integrating technology into mental health interventions. These devices, often worn on the body, collect real-time physiological data, enabling personalized and data-driven therapy. They enhance therapy effectiveness by monitoring vital signs, sleep patterns, and activity levels, providing therapists with objective insights. This continuous data stream fosters more targeted interventions and allows for timely adjustments to treatment plans.
The anxiety disorders segment is expected to have the highest CAGR during the forecast period
The anxiety disorders segment is anticipated to witness the highest CAGR growth during the forecast period. Digital psychotherapeutics offer promising solutions for anxiety disorders by providing accessible, personalized, and scalable interventions. These platforms often incorporate evidence-based therapeutic techniques, cognitive-behavioural therapy modules, and mindfulness practices to address anxiety symptoms. It's convenient and flexible approach to mental health care fuels the segment demand.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing awareness of mental health issues, rising smartphone penetration, and advancements in technology. The covid-19 pandemic's impact on mental health raised the acceptance of telehealth in the region. China is well-known for its strong technology infrastructure and telemedicine, mobile health applications, & wearable gadgets have seen tremendous improvements in the country. Thereby, robust advancements in telemedicine and digital health technology is likely to continue pushing growth in the region.
North America is projected to have the highest CAGR over the forecast period owing to the favourable reimbursement scenarios. The digital psychotherapeutics industry in the United States is expected to progress as the country's mental health awareness grows. Anxiety, depression, and post-traumatic stress disorder (PTSD) are common mental health illnesses in the United States. North America is a key player in shaping the future of digital psychotherapeutics, fostering innovation and accessibility. The region's well-established healthcare infrastructure, coupled with a growing acceptance of digital interventions, fosters market expansion.
Key players in the market
Some of the key players profiled in the Digital Psychotherapeutics Market include Pear Therapeutics, Akili Interactive, Happify Health, Headspace, Ginger, Lantern, Limbix, Big Health, Mindstrong Health, NeuroFlow, SilverCloud Health, Talkspace, Woebot Health, Kaia Health, Novartis, Spring Health, Koa Health and Meru Health.
In November 2023, Spring Health, the most comprehensive global mental health solution for employers and health plans, announced the launch of a new dedicated teen experience. Spring Health for teens is the latest innovation in the Family Care suite of services, which offers mental health care and support for all ages.
In November 2018, Sandoz, a division of Novartis partnered with Pear Therapeutics and launched reSET - a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA. reSET is a 12-week digital cognitive behavioral therapy program accessed through an app and designed to accompany outpatient care delivered by a physician.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.